封面
市場調查報告書
商品編碼
1413879

生物製造中的病毒檢測和定量市場:按產品類型、技術、應用和最終用戶分類 - 2024-2030 年全球預測

Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物製造領域的病毒檢測和定量市場規模預計到2023年為26.7億美元,2024年達到28.9億美元,2030年達到47.1億美元,複合年成長率為8.40%。

生物製造中病毒檢測和定量的全球市場

主要市場統計
基準年[2023] 26.7億美元
預測年份 [2024] 28.9億美元
預測年份 [2030] 47.1億美元
複合年成長率(%) 8.4%
生物製造病毒檢測與定量市場-IMG1

生物製藥製造市場中的病毒檢測和定量涵蓋涉及生物製藥製造流程中病毒污染物識別和測量的技術、服務和解決方案的開發、生產和商業化的行業和部門。增加對生物製藥研究和開發的投資正在促進市場成長。在備受矚目的污染事件後,人們對產品安全的認知不斷提高,加上嚴格的監管要求的訂定,正在推動生物製造市場中病毒檢測和定量的業務成長。然而,高昂的測試成本和複雜的監管核准流程可能會對中小企業造成進入壁壘,影響市場競爭。此外,需要高技能人員執行和解釋複雜的檢測也增加了市場空間的操作挑戰。此外,新型病毒去活化方法和即時病毒檢測技術的開拓將為市場帶來創新機會。跨不同平台的檢測標準化的研究舉措為市場提供了巨大的成長潛力。

區域洞察

美國和加拿大是生物製造病毒檢測和定量的關鍵市場。這些美洲地區的特點是先進的醫療保健系統、較高的人均醫療費用以及嚴格的生技藥品安全性和有效性法規環境。在歐洲國家,生物製造業不斷進步,注重創新、品質和安全。該歐洲、中東和非洲地區的客戶熱衷於採用符合歐盟嚴格法規結構的尖端病毒檢測技術。由於醫療保健投資增加和生物製藥需求不斷成長,中東地區呈現出有希望的成長。由於消費者對本地生產和進口生技藥品品質保證的需求不斷增加,中東地區的病毒檢測和定量市場仍處於起步階段。由於強勁的經濟成長、不斷成長的醫療支出和不斷擴大的技術採用,亞太地區的生物製造領域正在經歷快速成長。亞太地區快速成長的疫苗生產產業和出口市場推動了對病毒檢測和定量解決方案的需求,客戶更喜歡經濟高效且可靠的技術。

FPNV定位矩陣

FPNV定位矩陣對於評估生物製造市場中的病毒檢測和定量至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可以對生物製造市場病毒檢測和定量供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-生物製造中病毒檢測和定量市場的市場規模和預測是多少?

2-在生物製造市場病毒檢測和定量的預測期內,需要考慮投資哪些產品、細分市場、應用和領域?

3-生物製造中病毒檢測和定量市場的技術趨勢和法律規範是什麼?

4-生物製造市場病毒檢測和定量主要廠商的市場佔有率是多少?

5-進入生物製造病毒檢測和定量市場的適當型態和策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 病毒性疾病發生率不斷增加,需要增強檢測技術
      • 藥物開發和製造流程的指數級投資
      • 對攜帶式照護端關鍵測試的需求不斷成長
    • 抑制因素
      • 缺乏熟練人員及量化設備成本高
    • 機會
      • 病毒檢測和定量方法的快速進步
      • 重點關注病毒污染物的環境監測
    • 任務
      • 與病毒量分離相關的技術困難
  • 市場區隔分析
    • 產品類型:高精度耗材升級
    • 技術:改進PCR技術的採用以實現高特異性
    • 應用:在疫苗和治療藥物生產的廣泛應用
    • 最終用戶:CRO 和 CDMO 擴大採用病毒定量
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章按產品類型分類的生物製造市場中的病毒檢測和定量

  • 消耗品
    • 配件
    • 套件和檢測
  • 裝置
  • 服務

第7章生物製造中的病毒檢測和定量市場:按技術分類

  • 酵素免疫分析法
  • 流式細胞儀
  • 斑塊測定
  • 聚合酶鍊式反應

第8章生物製造中的病毒檢測和定量市場:按應用分類

  • 血液和血液製品的製造
  • 細胞和基因治療產品的製造
  • 幹細胞產品的製造
  • 紙巾及紙巾產品的製造
  • 疫苗和治療藥物的製造

第9章生物製造中的病毒檢測和定量市場:按最終用戶分類

  • CRO 和 CDMO
  • 生命科學公司
  • 測試實驗室

第10章美洲生物製造的病毒檢測與定量市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區生物製造中的病毒檢測與定量市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲生物製造領域的病毒檢測和定量市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:主要企業
  • 主要企業競爭情境分析
    • 新產品發布和功能增強
    • 獎項/獎勵/擴展

第14章競爭產品組合

  • 主要公司簡介
    • Agilent Technologies, Inc.
    • BASF SE
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Charles River Laboratories
    • Danaher Corporation
    • Genscript Biotech Corporation
    • Hamilton Company
    • Illumina, Inc.
    • LG Chem, Ltd.
    • Lonza Group Ltd.
    • Merck KGaA
    • New England Biolabs
    • Norgen Biotek Corp.
    • Oxford Nanopore Technologies PLC
    • PerkinElmer, Inc.
    • Promega Corporation
    • QIAGEN NV
    • Recipharm AB
    • Sartorius AG
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Thomas Scientific LLC
    • Zymo Research Corporation
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5AFA5

[194 Pages Report] The Biomanufacturing Viral Detection & Quantification Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.89 billion in 2024, at a CAGR 8.40% to reach USD 4.71 billion by 2030.

Global Biomanufacturing Viral Detection & Quantification Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 4.71 billion
CAGR (%) 8.4%
Biomanufacturing Viral Detection & Quantification Market - IMG1

The biomanufacturing viral detection and quantification market encompasses the industries and sectors involved in developing, producing, and commercializing technologies, services, and solutions for identifying and measuring viral contaminants in the biomanufacturing process. The increased investments in biopharmaceutical R&D is contributing to the market growth. The heightened awareness of product safety following high-profile contamination cases and the introduction of stringent regulatory requirements drive the business growth in the biomanufacturing viral detection & quantification market. However, the high costs of testing and the complexity of regulatory approval processes may create barriers to entry for smaller companies, affecting market competitiveness. The need for highly skilled individuals to perform and interpret complex assays adds to market space operational challenges. Moreover, developing novel viral inactivation methods and real-time viral detection technologies creates innovative opportunities in the market. The research initiative, which is directed towards standardizing assays across different platforms, creates significant growth potential in the market.

Regional Insights

In the Americas, the United States and Canada are pivotal markets for biomanufacturing viral detection and quantification. These Americas region is characterized by advanced healthcare systems, high per capita healthcare spending, and stringent regulatory environments that govern the safety and efficacy of biologics. In the European countries, the biomanufacturing sector is advanced with a strong emphasis on innovation, quality, and safety. Customers in this EMEA region are keen on adopting state-of-the-art viral detection technologies that align with the stringent EU regulatory frameworks. The Middle East shows promising growth with increased healthcare investments and a rising demand for biopharmaceuticals. The market for viral detection and quantification in the Middle East region is nascent, with a growing consumer need for quality assurance in locally produced and imported biologics. The Asia Pacific region is experiencing surge in the biomanufacturing domain, due to robust economic growth, increasing healthcare expenditures, and growing technological adoption. The demand for viral detection and quantification solutions is driven by the burgeoning vaccine production sector and export market in the APAC region, with customers showing a preference for cost-effective yet reliable technologies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomanufacturing Viral Detection & Quantification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomanufacturing Viral Detection & Quantification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering Type
    • Consumables
      • Accessories
      • Kits & Assays
    • Instruments
    • Services
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Flow Cytometry
    • Plaque Assay
    • Polymerase Chain Reaction
  • Application
    • Blood & Blood Products Manufacturing
    • Cellular & Gene Therapy Products Manufacturing
    • Stem Cell Products Manufacturing
    • Tissue & Tissue Products Manufacturing
    • Vaccines & Therapeutics Manufacturing
  • End User
    • CROs & CDMOs
    • Life Science Companies
    • Testing Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biomanufacturing Viral Detection & Quantification Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomanufacturing Viral Detection & Quantification Market?

3. What are the technology trends and regulatory frameworks in the Biomanufacturing Viral Detection & Quantification Market?

4. What is the market share of the leading vendors in the Biomanufacturing Viral Detection & Quantification Market?

5. Which modes and strategic moves are suitable for entering the Biomanufacturing Viral Detection & Quantification Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biomanufacturing Viral Detection & Quantification Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
      • 5.1.1.2. Exponential investments in drug development and manufacturing processes
      • 5.1.1.3. Growing demand for portable and point-of-care vital testing
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid advancements in viral testing and quantification methods
      • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
    • 5.1.4. Challenges
      • 5.1.4.1. Technical difficulties associated with the isolation of viral load
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering Type: Advances in consumables for high accuracy
    • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
    • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
    • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.3.1. Accessories
    • 6.3.2. Kits & Assays
  • 6.3. Instruments
  • 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Plaque Assay
  • 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Products Manufacturing
  • 8.3. Cellular & Gene Therapy Products Manufacturing
  • 8.4. Stem Cell Products Manufacturing
  • 8.5. Tissue & Tissue Products Manufacturing
  • 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

  • 9.1. Introduction
  • 9.2. CROs & CDMOs
  • 9.3. Life Science Companies
  • 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
      • 13.3.1.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
    • 13.3.2. Award, Recognition, & Expansion
      • 13.3.2.1. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Agilent Technologies, Inc.
    • 14.1.2. BASF SE
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. bioMerieux SA
    • 14.1.6. Charles River Laboratories
    • 14.1.7. Danaher Corporation
    • 14.1.8. Genscript Biotech Corporation
    • 14.1.9. Hamilton Company
    • 14.1.10. Illumina, Inc.
    • 14.1.11. LG Chem, Ltd.
    • 14.1.12. Lonza Group Ltd.
    • 14.1.13. Merck KGaA
    • 14.1.14. New England Biolabs
    • 14.1.15. Norgen Biotek Corp.
    • 14.1.16. Oxford Nanopore Technologies PLC
    • 14.1.17. PerkinElmer, Inc.
    • 14.1.18. Promega Corporation
    • 14.1.19. QIAGEN N.V.
    • 14.1.20. Recipharm AB
    • 14.1.21. Sartorius AG
    • 14.1.22. Shimadzu Corporation
    • 14.1.23. Takara Bio Inc.
    • 14.1.24. Thermo Fisher Scientific Inc.
    • 14.1.25. Thomas Scientific LLC
    • 14.1.26. Zymo Research Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET DYNAMICS
  • FIGURE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY PLAQUE ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STEM CELL PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TISSUE & TISSUE PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY VACCINES & THERAPEUTICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET LICENSE & PRICING